Free Trial

Principal Financial Group Inc. Has $23.46 Million Position in Encompass Health Corporation (NYSE:EHC)

Encompass Health logo with Medical background

Principal Financial Group Inc. decreased its position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 22.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 231,673 shares of the company's stock after selling 67,554 shares during the period. Principal Financial Group Inc. owned 0.23% of Encompass Health worth $23,464,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Colonial Trust Co SC acquired a new stake in Encompass Health in the fourth quarter worth approximately $29,000. Transce3nd LLC acquired a new stake in Encompass Health in the fourth quarter worth approximately $40,000. CBIZ Investment Advisory Services LLC lifted its position in Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after purchasing an additional 127 shares during the period. Signaturefd LLC lifted its position in shares of Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after acquiring an additional 125 shares during the last quarter. Finally, Arlington Trust Co LLC lifted its position in shares of Encompass Health by 22.9% during the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock valued at $68,000 after acquiring an additional 125 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. Wall Street Zen downgraded Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. Truist Financial reaffirmed a "buy" rating and issued a $135.00 target price (up previously from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price for the company in a research report on Thursday, June 5th. UBS Group raised their target price on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Finally, Royal Bank Of Canada raised their target price on Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th. Seven equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $131.50.

Read Our Latest Research Report on EHC

Insider Buying and Selling at Encompass Health

In other Encompass Health news, insider Elissa Joy Charbonneau sold 4,279 shares of the firm's stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total transaction of $498,974.19. Following the transaction, the insider directly owned 11,958 shares in the company, valued at $1,394,422.38. This trade represents a 26.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Mark J. Tarr sold 118,384 shares of the firm's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total value of $14,387,207.52. Following the completion of the sale, the chief executive officer directly owned 527,070 shares in the company, valued at approximately $64,054,817.10. This represents a 18.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 132,663 shares of company stock worth $16,034,082 over the last three months. Corporate insiders own 2.00% of the company's stock.

Encompass Health Stock Up 0.9%

Shares of NYSE:EHC traded up $1.01 during midday trading on Friday, hitting $118.50. 885,148 shares of the stock were exchanged, compared to its average volume of 707,780. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.06 and a current ratio of 1.06. Encompass Health Corporation has a 52-week low of $82.74 and a 52-week high of $123.13. The business's fifty day simple moving average is $119.58 and its two-hundred day simple moving average is $106.20. The company has a market capitalization of $11.95 billion, a PE ratio of 24.48, a P/E/G ratio of 2.39 and a beta of 0.88.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.18. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The business had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same period last year, the company earned $1.12 earnings per share. Encompass Health's quarterly revenue was up 10.6% compared to the same quarter last year. As a group, research analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.68 annualized dividend and a yield of 0.57%. Encompass Health's dividend payout ratio (DPR) is currently 14.05%.

About Encompass Health

(Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Featured Articles

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Should You Invest $1,000 in Encompass Health Right Now?

Before you consider Encompass Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Encompass Health wasn't on the list.

While Encompass Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines